Catherine Schulte

Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused...

Baird reiterated its Outperform rating on Exact Sciences Corporation (NASDAQ: EXAS) as analyst Catherine Schulte set a new $40 price target. 3 Key Points Strong Management Team: Schulte highlighted Exact Sciences' strong management, with its CEO and chief operations officer both having prior...